Fundz

Ribbon Biolabs Raises Eur 18 Million Series A Financing Enabling Commercial Scale Production Facilities And Us Expansion For Dna Synthesis Technology

PRIVATEJan 31, 2022

Amount Raised

€18 Million

Round Type

Series A

ViennaBiotechnologyHealth Care

Description

Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from Lansdowne Partners, Helicase Venture as well as several undisclosed investors. Existing investors IST cube and tecnet equity also joined in the round.

Quick answer

Ribbon Biolabs raised €18 Million in a Series A round, dated January 31, 2022. Ribbon Biolabs is based in Vienna, Illinois, United States.

How much did Ribbon Biolabs raise?
Ribbon Biolabs raised €18 Million in a Series A round on January 31, 2022.
What does Ribbon Biolabs do?
Ribbon Biolabs is a synthetic biology company advancing a new technology for the automated synthesis of long DNA molecules to enable innovation in the life sciences.
Where is Ribbon Biolabs based and how big is it?
Ribbon Biolabs is based in Vienna, Illinois, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Ribbon Biolabs that raised within 45 days of this round, from Fundz verified event records.

  • U.S. Renal Care raised $2.8M (Seed) on March 17, 2022.
  • Canopy raised $13M (Funding Round) on March 17, 2022.
  • Triumvira Immunologics Inc. raised an undisclosed amount (Series A) on March 17, 2022.
  • 2seventy bio raised $170M (Post-IPO Equity) on March 16, 2022.
  • Aptatek BioSciences raised $4M (Seed) on March 16, 2022.
  • KayoThera, Inc. raised $8M (Series A) on March 16, 2022.

Who to call at Ribbon Biolabs, and when

A new round usually means Ribbon Biolabs is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ribbon Biolabs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ribbon Biolabs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ribbon Biolabs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ribbon Biolabs

Location

Vienna, Illinois, United States

About

Ribbon Biolabs is a synthetic biology company advancing a new technology for the automated synthesis of long DNA molecules to enable innovation in the life sciences. With its proprietary technology in place, Ribbon Biolabs aims to be an inflection point in the continuing growth of the Bio-Economy by becoming the leading partner for long DNA molecules.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ribbon Biolabs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Ribbon Biolabs's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Ribbon Biolabs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.